 December
13, 2006 (FinancialWire) MIV Therapeutics Inc (OTCBB: MIVT) gained
31.65% Tuesday on volume of 2,455,106, which was almost 13 times its
three-month average 190,280, to end the day at $1.04.
December
13, 2006 (FinancialWire) MIV Therapeutics Inc (OTCBB: MIVT) gained
31.65% Tuesday on volume of 2,455,106, which was almost 13 times its
three-month average 190,280, to end the day at $1.04.
Companies
in the sector include Medtronic Inc. (NYSE: MDT), Boston Scientific
Corp. (NYSE: BSX), and Johnson & Johnson (NYSE: JNJ).
MIV
Therapeutics was enrolled in Investrend Research affiliate SISM
Research's professional analyst program. Complete information is
available at the company's InvestorPower page, which is accessible from
http://www.investrend.com/company/list.asp?sPathParam=yes .
For up-to-the-minute news, features and links click on http://www.FinancialWire.net
FinancialWire
is an independent, proprietary news service of Investrend Information,
a division of Investrend Communications, Inc. It is not a press release
service and receives no compensation from any company for its news or
opinions. Other divisions of Investrend, however, provide shareholder
empowerment platforms such as forums, independent research and
webcasting. For more information or to receive the FirstAlert daily
summary of news, commentary, research reports, webcasts, events and
conference calls, click on http://www.investrend.com/contact.asp
For a free annual report on a company mentioned in the news, please click on http://investrend.ar.wilink.com/?level=279
To
become an investor monitor of independent research for a company in
which you are invested, go to the not-for-profit Shareholders Research
Alliance, Inc. website by clicking on http://www.shareholdersresearch.com/
The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www.investrend.com/XmlFeeds?level=268
PRINT THIS PAGE | SEND IT TO A FRIEND | | | |
|
|